Lushan Yu[Author] - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2005	1
2006	1
2007	2
2008	2
2009	1
2010	2
2011	7
2012	10
2013	12
2014	18
2015	10
2016	9
2017	9
2018	5
2019	7
2020	15
2021	12
2022	10
2023	7
2024	5

1

INTEDE: interactome of drug-metabolizing enzymes.

Yin J, Li F, Zhou Y, Mou M, Lu Y, Chen K, Xue J, Luo Y, Fu J, He X, Gao J, Zeng S, Yu L, Zhu F. Yin J, et al. Among authors: yu l. Nucleic Acids Res. 2021 Jan 8;49(D1):D1233-D1243. doi: 10.1093/nar/gkaa755. Nucleic Acids Res. 2021. PMID: 33045737 Free PMC article.

2

Feature, Function, and Information of Drug Transporter-Related Databases.

Yin J, Li F, Li Z, Yu L, Zhu F, Zeng S. Yin J, et al. Among authors: yu l. Drug Metab Dispos. 2022 Jan;50(1):76-85. doi: 10.1124/dmd.121.000419. Epub 2021 Aug 23. Drug Metab Dispos. 2022. PMID: 34426411 Review.

3

The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.

Wang Y, Wang Y, Qin Z, Cai S, Yu L, Hu H, Zeng S. Wang Y, et al. Among authors: yu l. Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):291-306. doi: 10.1080/17425255.2021.1887139. Epub 2021 Feb 22. Expert Opin Drug Metab Toxicol. 2021. PMID: 33544643 Review.

4

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.

Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L. Zhou J, et al. Among authors: yu l. Front Pharmacol. 2020 Mar 20;11:343. doi: 10.3389/fphar.2020.00343. eCollection 2020. Front Pharmacol. 2020. PMID: 32265714 Free PMC article. Review.

5

VARIDT 2.0: structural variability of drug transporter.

Fu T, Li F, Zhang Y, Yin J, Qiu W, Li X, Liu X, Xin W, Wang C, Yu L, Gao J, Zheng Q, Zeng S, Zhu F. Fu T, et al. Among authors: yu l. Nucleic Acids Res. 2022 Jan 7;50(D1):D1417-D1431. doi: 10.1093/nar/gkab1013. Nucleic Acids Res. 2022. PMID: 34747471 Free PMC article.

6

Progress and trends on the analysis of nucleic acid and its modification.

Ouyang J, Zhan X, Guo S, Cai S, Lei J, Zeng S, Yu L. Ouyang J, et al. Among authors: yu l. J Pharm Biomed Anal. 2020 Nov 30;191:113589. doi: 10.1016/j.jpba.2020.113589. Epub 2020 Sep 3. J Pharm Biomed Anal. 2020. PMID: 32942104 Review.

7

Stereoselective binding of chiral drugs to plasma proteins.

Shen Q, Wang L, Zhou H, Jiang HD, Yu LS, Zeng S. Shen Q, et al. Acta Pharmacol Sin. 2013 Aug;34(8):998-1006. doi: 10.1038/aps.2013.78. Epub 2013 Jul 15. Acta Pharmacol Sin. 2013. PMID: 23852086 Free PMC article. Review.

8

LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.

Zhou Y, Sun W, Qin Z, Guo S, Kang Y, Zeng S, Yu L. Zhou Y, et al. Among authors: yu l. Biochem Pharmacol. 2021 Jul;189:114228. doi: 10.1016/j.bcp.2020.114228. Epub 2020 Sep 23. Biochem Pharmacol. 2021. PMID: 32976832 Review.

9

Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.

Wang J, Yu L, Jiang H, Zheng X, Zeng S. Wang J, et al. Among authors: yu l. Drug Metab Dispos. 2020 Sep;48(9):759-768. doi: 10.1124/dmd.120.000008. Epub 2020 Jun 29. Drug Metab Dispos. 2020. PMID: 32601104 Review.

10

Metabolism and pharmacokinetic study of deuterated osimertinib.

Zhan X, Bao S, Li X, Zhou S, Dahar MR, Lin N, Chen X, Niu C, Ji K, Wu Y, Zeng K, Tang Z, Yu L. Zhan X, et al. Among authors: yu l. Biopharm Drug Dispos. 2023 Apr;44(2):165-174. doi: 10.1002/bdd.2347. Epub 2023 Feb 3. Biopharm Drug Dispos. 2023. PMID: 36649539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year